Quality Control North West

What Quality Control North West does

Quality Control North West (QCNW) is an NHS pharmaceutical quality control laboratory services provider operating two sites — Stockport (headquarters at Stepping Hill Hospital) and Liverpool (Pharmacy Practice Unit) — as part of Stockport NHS Foundation Trust. Founded in the 1980s, QCNW delivers batch release testing, API/excipient testing, environmental monitoring, cleanroom monitoring, cytotoxic residue monitoring, stability studies, water analysis, and piped medical gas testing to NHS manufacturing units, public healthcare bodies, commercial pharmaceutical companies, and veterinary medicines manufacturers. The organization holds UKAS ISO/IEC 17025:2017 accreditation and MHRA GMP certification for both human and veterinary medicinal products, and operates since 2018 as a standalone MHRA-registered laboratory.

QCNW's technology stack centers on classical pharmacopoeial methods and modern analytical instrumentation, including LC, GC, LC/MS, FTIR, CE/CZE, UV, and atomic absorption/emission systems for pharmaceutical chemistry, and microbiological methods for environmental monitoring supported by the MRS3 reporting system. In February 2022, QCNW installed an Agilent Ultivo Triple Quadrupole Mass Spectrometer for cytotoxic residue monitoring, and its Liverpool laboratory operates specialized biological molecule analysis equipment (HPLC/SEC, PAGE, capillary electrophoresis, sub-visible particulate analyser, ELISA) for monoclonal antibody formulation and stability studies. Cellular bioassays are sub-contracted to a partner research laboratory.

The business model is transaction-fee based: clients register on the secure portal, submit purchase orders with sample request forms, and pay for each testing engagement on quote-based pricing. Multi-year contracts exist with NHS and pharmaceutical clients. QCNW has 36 employees and is led by Head of QCNW Diane Rigge (28 years of experience, Fellow of the Royal Society of Chemistry), with a team of advanced scientists across chemistry, microbiology, and business development. The organization holds representation on national NHS committees including the National Pharmaceutical Production Committee, National Piped Medical Gases Committee, and National NHS R&D Committee, reinforcing its institutional position within UK pharmaceutical quality assurance.

Name

Quality Control North West

Legal name

Stockport Quality Control North West

Website

https://qcnw-stockport.nhs.uk

Company type

Private

Founded year

1980

Operating status

Operating

Headcount range

11–50 employees

Short description

Quality Control North West is an NHS pharmaceutical quality control laboratory operating dual sites in Stockport and Liverpool, providing batch release testing, environmental monitoring, cytotoxic residue monitoring, stability studies, and biological molecule analysis to NHS trusts, commercial pharmaceutical companies, and veterinary medicines manufacturers under UKAS and MHRA GMP certification.

Ownership category

akta.pro rank

Product category

Pharmaceutical Quality Control Services

NAICS

Testing Laboratories and Services (541380), Testing Laboratories and Services (54138)

SIC

Services-Testing Laboratories (8734), Services-Commercial Physical & Biological Research (8731)

akta.pro primary industry

Analytical Development & QC Testing (Release/Stability/Potency) (HLAGAGAF)

akta.pro secondary industries

Analytical Testing & QC Release Services (potency, purity, sterility) (HLAAAKAG), Microbiology & Sterility Assurance (Bioburden/Endotoxin/Sterility) (HLAGADAE), Environmental Monitoring & Cleanroom Testing (GMP) (HLAGADAL), Release Testing & Batch Certification (QC) (HLAGADAC), Water & Utility Testing (PW/WFI/Steam/Gases) (HLAGADAO), Manufacturing Quality, GMP Inspections & Compliance (HLAJADAG)

Keywords

• Pharmaceutical quality control
• Batch release testing
• Environmental monitoring
• Stability studies
• Analytical chemistry services

Headquarters

HQ city

Stockport

HQ country

United Kingdom

HQ region

Europe

Offices2 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Infrastructure

Revenue model

1. Pharmaceutical Quality Control Testing Services: Contract laboratory testing services for NHS manufacturing units and pharmaceutical industry including batch release testing, API/excipient testing, environmental monitoring, cleanroom monitoring, water analysis, stability studies, cytotoxic residue monitoring, and medical gas testing. Testing requires purchase order prior to samples being sent.
2. Batch Release Testing: Comprehensive batch release testing services including finished product testing, microbiological testing, packaging component analysis, method development and validation for pharmaceuticals, veterinary medicines, nutraceuticals, and medical devices.
3. API/Excipient Testing: Quality control testing of Active Pharmaceutical Ingredients and excipients to pharmacopoeial or customer specifications.
4. Quality System Consultancy: Consultancy services for quality system maintenance and development.

Pricing tiers

Go-to-market motion2 records

Distribution channels1 record

Marketing channels4 records

Core offering

Quality Control North West (QCNW) is an NHS-embedded contract testing laboratory delivering pharmaceutical quality control services through dual UKAS ISO/IEC 17025:2017-accredited and MHRA GMP-certified sites at Stockport and Liverpool. The portfolio covers pharmaceutical chemistry and microbiology testing, batch release testing, API/excipient testing, environmental and cleanroom monitoring, cytotoxic residue monitoring, stability studies, water analysis, medical gas pipeline testing, biological molecule formulation studies, and supporting quality system consultancy and audit services for NHS manufacturing units, commercial pharmaceutical companies, veterinary medicines manufacturers, and biopharmaceutical clients.

Product overview

Quality Control North West (QCNW) is an NHS organisation providing a comprehensive range of pharmaceutical quality control services delivered through two laboratory sites (Stockport and Liverpool) under Stockport NHS Foundation Trust. The portfolio consists of a unified service offering of interconnected testing and consultancy capabilities. Core laboratory services span Pharmaceutical Chemistry (chromatographic, spectroscopic, and classical pharmacopoeial testing via LC, GC, LC/MS, FTIR, CE/CZE, UV, and atomic absorption/emission), Pharmaceutical Microbiology (environmental monitoring, sterility, endotoxins, preservative efficacy), and Biological Molecule analysis (HPLC/SEC, PAGE, capillary electrophoresis, ELISA). Supporting service modules include Ad-hoc Sample Analysis, API/Excipient Testing, Batch Release Testing, Cleanroom Monitoring, Cytotoxic Residue Monitoring, Piped Medical Gas Testing, Stability Studies, and Water Analysis. Cross-cutting service offerings include Environmental Monitoring (aligned with EU GMP Annex 1 and MHRA requirements), Quality System Consultancy, Audit services, Education and Training, and Wholesale Dealing. All services operate under UKAS ISO/IEC 17025:2017 accreditation and MHRA GMP compliance.

Differentiator

Problem solved

Functional benefit

Products and services

• Environmental Monitoring Comprehensive microbiological environmental monitoring services for cleanroom environments, including EM programmes designed to detect, assess and mitigate microbial risks. Services align with EU GMP Annex 1 and MHRA requirements, supported by genus-level classical identification and species-level MALDI-TOF identification, with trend analysis and reporting via MRS3.

Quantifiable outcome

• Successfully transitioned to ISO 17025:2017 standard following UKAS inspection (November 2019)
• +2 more outcomes

Named customers4 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Integration1 record

Feature4 records

Partnerships

Eight partnerships are on record, tiered minor and core.

• BSAC International Collaborative Drug Stability Testing ForumminorStrategic or Co-development Partner · 16 April 2021NCIVAS stability studies undertaken by QCNW Stockport were published on the BSAC International Collaborative Drug Stability Testing Forum, showcasing QCNW's research capabilities in drug stability testing.
• Stockport PharmaceuticalsminorStrategic or Co-development Partner · 13 September 2018As of September 2018, Stockport QCNW laboratory was registered as a standalone facility separate from Stockport Pharmaceuticals MIA license. This separation enables QCNW to offer testing for both veterinary and human medicines under its own license.
• National NHS Research and Development CommitteecoreStrategic or Co-development Partner · 24 May 2018Dr Lyndsay Davies from QCNW was accepted as a member of the National NHS R&D Committee, bringing expertise in testing of biological molecules such as monoclonal antibodies. Phil Weir continues as a member alongside Lyndsay.
• North West Regional QA ServicecoreStrategic or Co-development PartnerQuality Control North West works closely with North West Regional QA Service and with pharmacy professionals in NW aseptic and production units. This partnership supports coordinated quality assurance across the regional NHS pharmaceutical network.
• National Piped Medical Gases CommitteecoreStrategic or Co-development PartnerQCNW has representation on the NHS Pharmaceutical Quality Assurance Committee (Medical Gas Sub-Group) and the National Piped Medical Gases Committee, contributing to national standards for medical gas testing.
• National Pharmaceutical Production CommitteecoreStrategic or Co-development PartnerQCNW has representation on the National Pharmaceutical Production Committee, contributing to NHS pharmaceutical production standards and quality assurance practices.
• NHS Pharmacy Professionals NetworkcoreStrategic or Co-development PartnerQCNW works closely with pharmacy professionals in Northwest aseptic and production units, providing quality control services and expertise to the regional NHS pharmaceutical network.
• Sub-contract Research Laboratory (Cellular Bioassays)minorImplementation/ SI/ Consulting PartnerCellular bioassays for biological molecule analysis are conducted with a sub-contract research laboratory, supplementing QCNW's in-house capabilities for comprehensive analysis of monoclonal antibodies and biological formulations.

Scale indicators5 records

Recent moves6 records

Expansion highlights5 records

Direct peers

• NHS MPU Quality Control (Manchester University NHS Foundation Trust): NHS in-house QC laboratory serving Manchester Foundation Trust's aseptic manufacturing units. Directly comparable NHS-owned QC lab operating in the same North West region with similar batch release, environmental monitoring, and aseptic QC services.

Regional players

• Pharmaceutical Manufacturing Services (North Tees and Hartlepool NHS Foundation Trust): NHS aseptic manufacturing unit with internal QC capability serving the North East region. Comparable NHS-owned pharmaceutical manufacturing + QC operating model outside QCNW's region.
• Clinical Pharmacy Services (Royal Liverpool University Hospitals): Adjacent NHS pharmacy QC services operating in the same North West region; shares QCNW's footprint but is structurally part of the host trust rather than a multi-trust service.

Broad incumbents

• Smithers (Smithers Rapra / Smithers Pharma): Contract research and testing organization with pharmaceutical QC, extractables/leachables, and stability testing services. Comparable scientific services serving pharma manufacturers.
• Intertek Pharmaceutical Services: Global Total Quality Assurance provider with pharmaceutical analytical chemistry, microbiology, and stability capabilities. Comparable to QCNW's chemistry and microbiology service lines at larger scale.
• Charles River Laboratories: Global CRO with end-to-end pharmaceutical and biopharmaceutical QC testing services including batch release, stability, microbiology, and biologics characterization — competing directly for commercial pharma clients.
• Eurofins Biopharma Product Testing: Global CRO offering pharmaceutical batch release testing, stability studies, microbiology, and method validation across a large international footprint. Directly comparable services at substantially greater scale.
• SGS Health & Nutrition: Global testing services provider with pharmaceutical QC, microbiology, and environmental monitoring capabilities. Competes for commercial pharma QC work with broader geographic reach and harmonized LIMS.
• LGC Group (Life Sciences): UK-headquartered life sciences measurement and testing business with pharmaceutical QC, reference materials, and stability testing capabilities. Closest UK-domiciled large-scale peer.

Emerging players

• York Bioanalytical Solutions: UK-based specialist bioanalytical CRO offering GMP-compliant LC-MS testing for small molecules and peptides. Comparable in niche cytotoxic and pharmaceutical residue monitoring space using similar LC-MS instrumentation.

Market position

Strengths4 records

Weaknesses5 records

Competitive moat4 records

Key risks6 records

Key highlights6 records

Customer concentration

• LinkedInlinkedin.com/company/quality-control-north-west

Compliance5 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles6 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Quality Control North West